ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer
Clinical trial NCT03950570 · COMPLETED
Trial details
- NCT number
- NCT03950570
- Sponsor
- Orinove, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-25
- Primary completion
- 2023-01-30
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.